Solving the medical needs of today
Our main pipeline focus is on indications with a particularly high, current medical need, for which no efficient solutions are available. Finding these solutions is one of AiCuris’ two priorities, and we highly invest into the appropriate selection of indication and approach. Our diverse program targets both viral and bacterial areas of unmet medical need, addressing niche markets as well as big indications.
Preparing for future threats
The global COVID -19 pandemic has taught the world that potential future infectious threats should not be underestimated. We are convinced that anti-microbial resistance (AMR) will become a significant threat to mankind in future and have actively worked on identifying new anti-bacterial agents since our inception. In 2020, we additionally launched a “Pandemic and Resistance Emergency Preparedness (PREP) program” and expanded our pipeline by targeting potential viral pandemics, including SARS-CoV-2.